|
OXR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.433600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.102200E-01 |
| Normal-vs-Stage2 |
4.660400E-02 |
| Normal-vs-Stage3 |
2.917000E-01 |
| Normal-vs-Stage4 |
1.033630E-01 |
| Stage1-vs-Stage2 |
2.444300E-02 |
| Stage1-vs-Stage3 |
1.891570E-01 |
| Stage1-vs-Stage4 |
8.851900E-02 |
| Stage2-vs-Stage3 |
2.165400E-01 |
| Stage2-vs-Stage4 |
5.906200E-01 |
| Stage3-vs-Stage4 |
4.913600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.871400E-01 |
| Normal-vs-AfricanAmerican |
1.725840E-01 |
| Normal-vs-Asian |
9.698200E-01 |
| Caucasian-vs-AfricanAmerican |
8.042100E-02 |
| Caucasian-vs-Asian |
5.475600E-01 |
| AfricanAmerican-vs-Asian |
1.854580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.555700E-02 |
| Normal-vs-Female |
8.360200E-01 |
| Male-vs-Female |
2.472200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.290800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.145600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.149800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.555830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.081000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.282500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.309800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.301800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.122800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.810000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.773700E-02 |
| Classical-VS-Follicular |
4.634800E-04 |
| Classical-VS-Other |
7.679800E-01 |
| Classical-VS-Normal |
6.087000E-01 |
| Tall-VS-Follicular |
3.791400E-01 |
| Tall-VS-Other |
5.905600E-01 |
| Tall-VS-Normal |
1.854200E-01 |
| Follicular-VS-Other |
4.252400E-01 |
| Follicular-VS-Normal |
1.766310E-02 |
| Other-VS-Normal |
8.799200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.039400E-01 |
| Normal-vs-N1 |
6.443600E-01 |
| N0-vs-N1 |
4.626000E-01 |
|
|
